Gaps between hypertension treatment guidelines and clinical practice in Japan: Baseline survey results from fukushima research of hypertension (FRESH)

Journal of Clinical Hypertension

Volumn 11, Issue 6, 2009, Pages 333-341

  Yokokawa, Hirohide ^a   Goto, Aya ^a   Sanada, Hironobu ^a,b   Watanabe, Tsuyoshi ^a   Yasumura, Seiji ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b NATIONAL VETERINARY ASSAY LABORATORY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE MEASUREMENT; BODY MASS; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; FAMILY HISTORY; FEMALE; GERIATRIC PATIENT; HEALTH SURVEY; HUMAN; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; OBESITY; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; VASCULAR DISEASE;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; COHORT STUDIES; DIABETES MELLITUS; FEMALE; GUIDELINE ADHERENCE; HEALTH SURVEYS; HUMANS; HYPERTENSION; JAPAN; KIDNEY DISEASES; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 67849135802     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2009.00118.x     Document Type: Article

References (49)

1. World Health Organization. Ten Statistical Highlights in Global Public Health. World Health Statistics 2006. http://www.who.int/whosis/ whostat2006_10highlights.pdf. Accessed June 1, 2008. 2006.
2. World Health Organization. Global Health: Today's Challenges. The World Health Report 2003. 2003. http://www.who.int/whr/2003/en/ Chapter1-en.pdf. Accessed June 1, 2008.
3. Chobanian AV, Bakris GL, Black HR, et al. National Heart, Lung, and Blood Institute Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report. JAMA. 2003;289:2560-2572.
4. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997;349:1436-1442.
5. Cherry DK, Woodwell DA, Rechtsteiner EA. National Ambulatory Medical Care Survey: 2005 summary. Adv Data. 2007;387:1-39.
6. Whelton PK, He J, Appel LJ, et al. National High Blood Pressure Education Program Coordinating Committee. Primary prevention of hypertension: Clinical and public health advisory from The National High Blood Pressure Education Program. JAMA. 2002;288:1882-1888.
7. Mechanic D, McAlpine DD, Rosenthal M. Are patients' office visits with physicians getting shorter? N Engl J Med. 2001;344:198-204.
8. Kikuya M, Hozawa A, Ohokubo T, et al. Prognostic significance of blood pressure and heart rate variabilities: The Ohasama study. Hypertension. 2000;36:901-906.
9. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med. 1993;153:598-615.
10. Flack JM, Neaton J, Grimm R Jr, et al. Blood pressure and mortality among men with prior myocardial infarction. Multiple Risk Factor Intervention Trial Research Group. Circulation. 1995;92:2437-2445.
11. Mancia G, De Backer G, Dominiczak A, et al; Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105-1187.
12. Whitworth JA; World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/ International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21:1983-1992.
13. National Kidney Foundation Kidney Disease Outcome and Quality Initiative (NKF/KDOQI). K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004;43(5 suppl 1):S1-S290.
14. Almdal T, Scharling H, Jensen JS, et al. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: A population-based study of 13,000 men and women with 20years of follow-up. Arch Intern Med. 2004;164:1422-1426.
15. Adler AI, Stratton IM, Neil HA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): Prospective observational study. BMJ. 2000;321:412-419.
16. The Japanese Society of Nephrology. Clinical Practice Guidebook for Diagnostic and Treatment of Chronic Kidney Disease. Tokyo: Tokyo Igakusya; 2007 (In Japanese).
17. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139:137-147.
18. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296-1305.
19. Deo R, Fyr CL, Fried LF, et al.; Health ABC study. Kidney dysfunction and fatal cardiovascular disease - an association independent of atherosclerotic events: Results from the Health, Aging, and Body Composition (Health ABC) study. Am Heart J. 2008;155:62-68.
20. Japanese Society of Hypertension. Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2004). Hypertens Res. 2006;29(suppl):S1-S105.
21. Kitamura A, Iso H, Iida M, et al. Trends in the incidence of coronary heart disease and stroke and the prevalence of cardiovascular risk factors among Japanese men from 1963 to 1994. Am J Med. 2002;112:104-109.
22. Kubo M, Kiyohara Y, Kato I, et al. Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: The Hisayama study. Stroke. 2003;34:2349-2354.
23. Ministry of Health and Welfare. 5th National Basic Survey for Circulatory Disease. http://www.mhlw.go.jp/toukei/saikin/hw/kenkou/ jyunkan/jyunkan00/gaiyo.html. Accessed June 1, 2008. 2001 (In Japanese).
24. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415-1428.
25. Spranger CB, Ries AJ, Berge CA, et al. Identifying gaps between guidelines and clinical practice in the evaluation and treatment of patients with hypertension. Am J Med. 2004;117:14-18.
26. Singer GM, Izhar M, Black HR. Goal-oriented hypertension management: translating clinical trials to practice. Hypertension. 2002;40:464-469.
27. Osuga E, Tamachi H, Hayakawa H. Blood pressure control in outpatients with hypertension after the publication of the JSH 2000 guidelines. Jpn J Clin Pharmacol Ther. 2003;34:283-288 (In Japanese).
28. Phan TL, Elias C, Nguyen TL, et al. The prevalence of reproductive tract infections in Hue, Vietnam. Stud Fam Plann. 2002;33:217-226.
29. Japan Diabetes Society. Diabetes Treatment Guideline 2008-2009, Tokyo: Bunkodo; 2008 (In Japanese).
30. Ministry of Health, Labor and Welfare & Ministry of Education, Culture, Sports, Science and Technology. Ethical Guideline for Epidemiological Studies. http://www-bm.mhlw.go.jp/general/seido/kousei/ i-kenkyu/ekigaku/0504sisin.html. Accessed June 1, 2008. 2007 (In Japanese).
31. Anonymous. World Medical Association Declaration of Helsinki. JAMA. 2000;284:3043-3045.
32. Yamamoto Y, Sonoyama K, Matsubara K, et al. The status of hypertension management in Japan in 2000. Hypertens Res. 2002;25:717-725.
33. Lloyd-Jones DM, Evans JC, Larson MG, et al. Differential control of systolic and diastolic blood pressure: Factors associated with lack of blood pressure control in the community. Hypertension. 2000;36:594-599.
34. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001;345:479-486.
35. Public Health Division, Ministry of Health, Labor and Welfare. National Survey of Health and Nutrition. http://www.mhlw.go.jp/houdou/2007/05/ h0516-3a.html. Accessed June 1, 2008. 2007 (In Japanese).
36. Reeves MJ, Rafferty AP. Healthy lifestyle characteristics among adults in the United States, 2000. Arch Intern Med. 2005;165:854-857.
37. Summary Health Statistics for U.S. Adults: National Health Interview Survey. 2006. http://www.cdc.gov/nchs/data/series/sr_10/sr10_235.pdf. Accessed June 1, 2008.
38. Brown CD, Higgins M, Donato KA, et al. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res. 2000;8:605-619.
39. Wilsgaard T, Schirmer H, Arnesen E. Impact of body weight on blood pressure with a focus on sex differences: The Tromso Study, 1986-1995. Arch Intern Med. 2000;160:2847-2853.
40. Rosenbaum M, Leibel RL, Hirsch J. Obesity. N Engl J Med. 1997;337:396-407.
41. Anonymous. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med. 1998;158:1855-1867.
42. Kiernan M, Winkleby MA. Identifying patients for weight-loss treatment: an empirical evaluation of the NHLBI obesity education initiative expert panel treatment recommendations. Arch Intern Med. 2000;160:2169-2176.
43. Tozawa M, Oshiro S, Iseki C, et al. Multiple risk factor clustering of hypertension in a screened cohort. J Hypertens. 2000;18:1379-1385.
44. Kannel WB, Wilson PW, Zhang TJ. The epidemiology of impaired glucose tolerance and hypertension. Am Heart J. 1991;121:1268-1273.
45. Bønaa KH, Thelle DS. Association between blood pressure and serum lipids in a population. The Tromsø Study. Circulation. 1991;83:1305-1314.
46. Knight EL, Bohn RL, Wang PS, et al. Predictors of uncontrolled hypertension in ambulatory patients. Hypertension. 2001;38:809-814.
47. Di Bari M, Salti F, Nardi M, et al. Undertreatment of hypertension in community-dwelling older adults: A drug-utilization study in Dicomano, Italy. J Hypertens. 1999;17:1633-1640.
48. Street RL Jr, Gordon HS, Ward MM, et al. Patient participation in medical consultations: Why some patients are more involved than others. Med Care. 2005;43:960-969.
49. Düsing R. Overcoming barriers to effective blood pressure control in patients with hypertension. Curr Med Res Opin. 2006;22:1545-1553.